跳至主要内容
临床试验/NCT04061538
NCT04061538已完成不适用

Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age

Instituto Nacional de Salud Publica, Mexico18 个研究点 分布在 1 个国家目标入组 529 人开始时间: 2017年11月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
529
试验地点
18
主要终点
Stool frequency

研究概览

简要总结

This study evaluates the effect of zinc over the duration, severity and relapse of acute diarrheic disease, in children between 6 and 59 months of age. One study group will receive a tablet that contains 20 mg of zinc, and the other study group will receive a tablet,that does not contain zinc, it is a tablet that investigators will use as control.

详细描述

In Mexico acute diarrheal diseases mortality in children continues to be a public health issue, being between the main causes of morbidity and mortality, with an important load for the health systems. Consequently, there exists a necessity for the implementation of alternate strategies for this condition, nutrition being one of the pillars to strengthen.

Zinc administration during the diarrhea episode is a simple intervention for clinical picture reduction and relapse. The recommendation of including zinc in the treatment of ADD is not part of the Mexican normativity. The evaluation of the efficacy of zinc administration in Mexican children is insufficient and a program or national strategy for zinc treatment does not exist.

The objective of this study is evaluates the efficacy of oral zinc sulfate administration, during the diarrhea clinic picture in children of Mexico City.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
6 Months 至 59 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Both sexes
  • Children attended in the sentinel centers
  • Clinical diagnosis of acute diarrhea disease
  • Parents have not planned moving to other location in a time period of at least one year.

排除标准

  • Deficient intestinal absorption syndrome
  • Acrodermatitis enterohepatic
  • Zinc sulfate hypersensitivity
  • Leucine metabolic disorders
  • Secondary lactose intolerance
  • Galactosemia lactase primary deficiency
  • Allergy to cow milk protein
  • Children that are supplemented with zinc for the last 6 months

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo tablet, once a day for 10 days

干预措施: Placebo (Dietary Supplement)

Zinc sulfate

Experimental

Zinc sulfate 20 mg by mouth, once a day for 10 days

干预措施: zinc sulfate (Dietary Supplement)

结局指标

主要结局

Stool frequency

时间窗: 10 days

Number of stools during during the acute diarrheic disease

Diarrhea duration

时间窗: 10 days

Number of hours from the inclusion of the patient until the end of the diarrhea. The end of diarrhea was defined as the last diarrhea evacuation followed by a 48 hr period without diarrhea

次要结局

  • zinc serum concentration(3, 9, 20, 31, 61, 91 and 121 days)
  • diarrheic disease recurrence(3 and 6 months)

研究者

发起方
Instituto Nacional de Salud Publica, Mexico
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jorge Salmeron Castro

Honorary researcher

Instituto Nacional de Salud Publica, Mexico

研究点 (18)

Loading locations...

相似试验